It has also been demonstrated that DOCK2 was abnormally elevated expressed in B‐cell lymphoma and the overexpressed DOCK2 correlated with the reduced prognosis of chronic lymphocytic leukaemia.40, 41. Here, DOCK2 is linked to B-cell non-Hodgkin lymphoma.